Medpace Central Labs Expand Histology & Anatomic Pathology Services
As part of our efforts to increase laboratory services and capabilities, Medpace is excited to share that we have expanded our central laboratory histology and…
[On-Demand Webinar] Liquid Biopsy in Oncology: Opportunities and Challenges
Join featured speakers from Medpace on September 8th, as they provide an overview of the current methodologies involved in liquid biopsies and their application for…
[Webinar] Establishing Efficacy with Flow Cytometry-Based Receptor Occupancy Assays
In this on-demand webinar, experienced scientists from Medpace’s central labs discuss how flow cytometric receptor occupancy assays — when correctly implemented — are a powerful…
5 Things You Didn’t Know About Medpace’s Biorepository Services
Medpace Biorepository, a CAP accredited facility, is a key component of Medpace Central Labs and the full-service model.
Medpace Bolsters In-House Central Lab Expertise with the Addition of Three New Scientists
Medpace is pleased to announce the addition of three scientists to our Central Laboratory leadership team.
China Central Lab Expansion
As part of our efforts to expand laboratory services and capabilities, specifically in Asia, Medpace has relocated our central laboratory facilities from Beijing to Shanghai.…
Ask an Expert: Understanding Regulation and Validation Processes for Biomarkers
We sat down with Christopher Daniels, Director, Clinical Laboratory Services at Medpace, to discuss regulations and standards for biomarkers, validation process for central labs, and…
Biorepository Risk Mitigation Plan: The Value of Specimen Storage for Clinical Research
In a process-oriented industry that breathes deeply from a standard set of regulations, it is easy to see the importance of each storage unit in…
Belgium Central Lab Expansion
As part of our efforts to expand laboratory services and capabilities, Medpace’s central lab in Belgium recently completed extensive expansions including a new modern laboratory…
4 Key Considerations for Designing Immuno-Oncology Trials
As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…